Johnell Brooks to Antipsychotic Agents
This is a "connection" page, showing publications Johnell Brooks has written about Antipsychotic Agents.
Connection Strength
0.838
-
Safety and tolerability associated with second-generation antipsychotic polytherapy in bipolar disorder: findings from the Systematic Treatment Enhancement Program for Bipolar Disorder. J Clin Psychiatry. 2011 Feb; 72(2):240-7.
Score: 0.301
-
Metabolic risks in older adults receiving second-generation antipsychotic medication. Curr Psychiatry Rep. 2009 Feb; 11(1):33-40.
Score: 0.269
-
Long-term effectiveness of quetiapine in bipolar disorder in a clinical setting. J Psychiatr Res. 2010 Oct; 44(14):921-9.
Score: 0.073
-
Depressive illness burden associated with complex polypharmacy in patients with bipolar disorder: findings from the STEP-BD. J Clin Psychiatry. 2009 Feb; 70(2):155-62.
Score: 0.067
-
Secondary mania in older adults. Am J Psychiatry. 2005 Nov; 162(11):2033-8.
Score: 0.054
-
Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions. J Psychiatr Res. 2006 Mar; 40(2):160-6.
Score: 0.053
-
Individual risk profiles for postoperative delirium after joint replacement surgery. Psychosomatics. 2011 Sep-Oct; 52(5):410-6.
Score: 0.020